Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

QNRXQNRX
2 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in QUOIN PHARMACEUTICALS LTD

No. Citadel Advisors exited its QNRX (Quoin Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 32,519 shares worth $214,625. Citadel Advisors first reported QNRX in Q1 2026 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$214,625

Total Shares Change

-32,519

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$4.84
0
2026-Q1
New
32,519
-
$214,6250.0%$6.60
35

Other major holders of QNRX: Woodline Partners LP, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used